References
1. Petrikkos G, Tsioutis C. Recent Advances in the Pathogenesis of
Mucormycoses. Clinical Therapeutics. 2018 Jun;40(6):894–902.
2. Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital
mucormycosis. Indian J Ophthalmol. 2021 Apr;69(4):1002–4.
3. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri
GD, Chakrabarti A, Agarwal R. Coronavirus Disease (Covid-19) Associated
Mucormycosis (CAM): Case Report and Systematic Review of Literature.
Mycopathologia. 2021 May;186(2):289-298. doi:
10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
4. Verma DK, Bali RK. COVID-19 and Mucormycosis of the Craniofacial
skeleton: Causal, Contributory or Coincidental? J Maxillofac Oral Surg.
2021 Jun;20(2):165–6.
5. Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A Review
of Ophthalmic Manifestations of COVID-19. Indian Journal of
Ophthalmology [Internet]. 2021;69(3). Available from:
https://journals.lww.com/ijo/Fulltext/2021/03000/COVID_19_and_Eye__A_Review_of_Ophthalmic.8.aspx
6. Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a Viral
Land: A Tale of Two Pathogens. Indian J Ophthalmol. 2021
Feb;69(2):244–52.
7. Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V.
Sino-orbital mucormycosis in a COVID-19 patient: A case report.
International Journal of Surgery Case Reports. 2021 May;82:105957.
8. Saldanha M, Reddy R, Vincent MJ. Title of the Article: Paranasal
Mucormycosis in COVID-19 Patient. Indian J Otolaryngol Head Neck Surg
[Internet]. 2021 Apr 22 [cited 2021 May 17]; Available from:
https://link.springer.com/10.1007/s12070-021-02574-0
9. Revannavar SM, P S S, Samaga L, V K V. COVID-19 triggering
mucormycosis in a susceptible patient: a new phenomenon in the
developing world? BMJ Case Rep. 2021 Apr;14(4):e241663.
10. Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, et
al. SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids—An Unholy
Trinity in Invasive Fungal Infections of the Maxillofacial Region? A
Retrospective, Multi-centric Analysis. J Maxillofac Oral Surg
[Internet]. 2021 Mar 6 [cited 2021 May 17]; Available from:
http://link.springer.com/10.1007/s12663-021-01532-1
11. Werthman-Ehrenreich A. Mucormycosis with orbital compartment
syndrome in a patient with COVID-19. The American Journal of Emergency
Medicine. 2021 Apr;42:264.e5-264.e8.
12. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC,
et al. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With
COVID-19-Associated Acute Respiratory Distress Syndrome. Ophthalmic
Plastic & Reconstructive Surgery. 2021 Mar;37(2):e40–80.
13. Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral Mucormycosis and
COVID-19 Pneumonia. J Med Cases. 2021/01/19 ed. 2021 Mar;12(3):85–9.
14. Johnson AK, Ghazarian Z, Cendrowski KD, Persichino JG. Pulmonary
aspergillosis and mucormycosis in a patient with COVID-19. Medical
Mycology Case Reports. 2021 Jun;32:64–7.
15. Khatri A, Chang K-M, Berlinrut I, Wallach F. Mucormycosis after
Coronavirus disease 2019 infection in a heart transplant recipient –
Case report and review of literature. Journal of Medical Mycology. 2021
Jun;31(2):101125.
16. Dallalzadeh LO, Ozzello DJ, Liu CY, Kikkawa DO, Korn BS. Secondary
infection with rhino-orbital cerebral mucormycosis associated with
COVID-19. null. 2021 Mar 23;1–4.
17. Placik DA, Taylor WL, Wnuk NM. Bronchopleural fistula development in
the setting of novel therapies for acute respiratory distress syndrome
in SARS-CoV-2 pneumonia. Radiology Case Reports. 2020
Nov;15(11):2378–81.
18. Kanwar A, Jordan A, Olewiler S, Wehberg K, Cortes M, Jackson BR. A
Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19. JoF.
2021 Feb 28;7(3):174.
19. Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali
H, et al. The double-edged sword of systemic corticosteroid therapy in
viral pneumonia: A case report and comparative review of
influenza-associated mucormycosis versus COVID-19 associated
mucormycosis. Mycoses. 2021 Feb 16;10.1111/myc.13256.
20. Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M,
Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19
patients: A case report. European Journal of Ophthalmology. 2021 Apr
10;112067212110094.
21. Karimi‐Galougahi M, Arastou S, Haseli S. Fulminant mucormycosis
complicating coronavirus disease 2019 (COVID‐19). Int Forum Allergy
Rhinol. 2021 Mar 13;alr.22785.
22. Monte Junior ES do, Santos MEL dos, Ribeiro IB, Luz G de O, Baba ER,
Hirsch BS, et al. Rare and Fatal Gastrointestinal Mucormycosis
(Zygomycosis) in a COVID-19 Patient: A Case Report. Clin Endosc. 2020
Nov 30;53(6):746–9.
23. Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon
S, Romero-Gutierrez L. A Case of Fatal Rhino-Orbital Mucormycosis
Associated With New Onset Diabetic Ketoacidosis and COVID-19. Cureus
[Internet]. 2021 Feb 5 [cited 2021 May 17]; Available from:
https://www.cureus.com/articles/51628-a-case-of-fatal-rhino-orbital-mucormycosis-associated-with-new-onset-diabetic-ketoacidosis-and-covid-19
24. Pasero D, Sanna S, Liperi C, Piredda D, Branca GP, Casadio L, et al.
A challenging complication following SARS-CoV-2 infection: a case of
pulmonary mucormycosis. Infection [Internet]. 2020 Dec 17 [cited
2021 May 17]; Available from:
http://link.springer.com/10.1007/s15010-020-01561-x
25. Zurl C, Hoenigl M, Schulz E, Hatzl S, Gorkiewicz G, Krause R, et al.
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a
Critically Ill COVID-19 Patient with Underlying Hematological
Malignancy. JoF. 2021 Jan 27;7(2):88.
26. Black fungus has claimed 52 lives in maharashtra so far:Official.
The Hindu [Internet]. 2021 May 14; Available from:
https://www.thehindu.com/news/national/other-states/black-fungus-has-claimed-52-lives-in-maharashtra-so-far-official/article34554570.ece
27. India reports 8,848 mucormycosis cases, 23k more Amphotericin vials
allocated. The times of India [Internet]. 2021 May 23; Available
from:
https://timesofindia.indiatimes.com/india/india-reports-8848-mucormycosis-cases-23k-more-amphotericin-vials-allocated/articleshow/82855964.cms